Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk

Documenti analoghi

• Potentially functional genetic variants in interferon regulatory factor family genes are associated with colorectal cancer survival
  di: Xiaoxia Tong, et al.
  Pubblicazione: (2024)
• Precision therapy for cancer prevention by targeting carcinogenesis
  di: Guoguo Jin, et al.
  Pubblicazione: (2024)
• Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis
  di: Ram Raj Prasad, et al.
  Pubblicazione: (2024)
• Systematical identification of key genes and regulatory genetic variants associated with prognosis of esophageal squamous cell carcinoma
  di: Linglong Gu, et al.
  Pubblicazione: (2024)
• Hypomethylation‐associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation‐mediated degradation of SND1
  di: Qi Lai, et al.
  Pubblicazione: (2024)